First Time Loading...

Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 4.11 USD 1.99%
Updated: May 6, 2024

Abcellera Biologics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Operating Income Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Operating Income
-$237.2m
CAGR 3-Years
N/A
CAGR 5-Years
-212%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Operating Income
-CA$5.1m
CAGR 3-Years
15%
CAGR 5-Years
-8%
CAGR 10-Years
-38%
Replicel Life Sciences Inc
XTSX:RP
Operating Income
-CA$1.4m
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Operating Income
-CA$219.6k
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
13%

See Also

What is Abcellera Biologics Inc's Operating Income?
Operating Income
-237.2m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Operating Income amounts to -237.2m USD.

What is Abcellera Biologics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-212%